Rubén González del Río

Repurposing clinically approved cephalosporins for tuberculosis therapy

Santiago Ramón‐García, Rubén González del Río, Angel Santos Villarejo et al. · Scientific Reports · 2016 · 92 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Development of an Intracellular Screen for New Compounds Able To Inhibit Mycobacterium tuberculosis Growth in Human Macrophages

Flavia Sorrentino, Rubén González del Río, Xingji Zheng et al. · Antimicrobial Agents and Chemotherapy · 2015 · 77 citations · Full text

Medicine, Microbiology, Pharmacology +12

Mycobacterium tuberculosis Gyrase Inhibitors as a New Class of Antitubercular Drugs

Delia Blanco, Esther Pérez‐Herrán, Mónica Cacho et al. · Antimicrobial Agents and Chemotherapy · 2015 · 45 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Release of 50 new, drug-like compounds and their computational target predictions for open source anti-tubercular drug discovery

María José Rebollo-López, Joël Lelièvre, Daniel Álvarez-Gómez et al. · PLoS ONE · 2015 · 45 citations · Full text

Pharmacy, Bioinformatics, Medicinal Chemistry +17

A Leucyl-tRNA Synthetase Inhibitor with Broad-Spectrum Antimycobacterial Activity

Uday S. Ganapathy, Rubén González del Río, Mónica Cacho-Izquierdo et al. · Antimicrobial Agents and Chemotherapy · 2021 · 41 citations · Full text

Medicine, Infectious Diseases, Pharmacology +5